Median CXCL13 concentrations in the CSF of patients with TBEV was 8.7 pg/ml while inflammatory diseases, facial palsy of unknown origin, primary headache, and other diseases had median CXCL13 levels of 4.5 pg/ml. The gene discussed is CXCL13; the disease is Facial palsy.